Lautert-Dutra W, Dos Reis RB, Squire JA
Neuroprotective Effects: GLP-1 agonists show potential for neuroprotection and cognitive improvement, which may be beneficial in neurodegenerative diseases
A 1 vice-corregedora do Conselho Regional de Medicina do Estado da Bahia (Cremeb), Marlia Niedermayer Fagundes, afirma que j existe ateno quanto oferta e divulgao de terapias que ainda no contam com evidncias cientficas robustas sobre eficcia e segurana
Based on animal research, potential interactions may occur with dopamine-affecting medications (Parkinson's drugs), blood pressure medications, anticoagulants (blood thinners), and immunosuppressants
doi: 10.1007/s12020-014-0361-4 60 NissenAMarstrandSSkov-JeppesenKBremholmLHornumMAndersenUBet al
Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency